What are the side effects of ipamorelin?

Why Ipamorelin Is Considered "Clean"

Unlike other growth hormone secretagogues (GHRP-2, GHRP-6, hexarelin), ipamorelin selectively stimulates GH release without significantly affecting cortisol or prolactin. This makes it the preferred GHRP for most clinical and research applications because:

• No cortisol elevation → no stress hormone surge
• No prolactin elevation → no hormonal side effects (gynecomastia, libido issues)
• Minimal ghrelin-receptor effects outside GH → less hunger stimulation
• Better tolerability at higher doses

Most Common Side Effects (Mild, Generally Transient)

Injection site reactions

• Mild redness, itching, or swelling at injection site
• Usually resolves within hours
• Rotate injection sites to prevent irritation
• If persistent or severe, may indicate contaminated pharmacy preparation

Headaches

• Mild to moderate headaches in first 1–2 weeks common
• Usually resolves with continued use
• Often responds to hydration and over-the-counter analgesics
• Related to initial GH/IGF-1 rise

Transient water retention

• Mild edema, particularly in hands and feet
• 2–4 lbs of temporary weight gain typical in first 2 weeks
• Usually resolves as body adapts
• More pronounced at higher doses

Flushing and warmth

• Brief warmth or flushing 10–20 minutes after injection
• Typically mild, resolves within 30 minutes
• Can occur with any peptide that affects histamine pathways

Tingling or numbness

• Mild tingling in hands, feet, or face
• Related to mild edema pressing on nerves
• Usually transient
• If persistent, may indicate carpal tunnel-like syndrome at higher doses

Moderate Side Effects

Blood sugar elevation

• GH and IGF-1 antagonize insulin to some degree
• Fasting glucose may rise 5–15 mg/dL
• HbA1c may rise 0.1–0.3%
• Clinically insignificant for most users
• Can be problematic for pre-diabetic or diabetic users
• Monitor if you have risk factors

Increased appetite

• Ipamorelin has minor ghrelin-mimicking properties
• Some users report increased hunger, though less than with GHRP-2 or GHRP-6
• Usually mild and manageable

Fatigue

• Occasional fatigue, especially in first weeks
• May relate to sleep architecture changes as GH patterns shift
• Usually resolves within 2–4 weeks

Joint stiffness or mild joint aches

• Related to water retention around joints
• Usually transient
• More pronounced at higher doses

Rare but Serious

Hypoglycemia in diabetics on insulin

• Unusual but possible
• Especially if stopping ipamorelin and insulin dose wasn't adjusted during use
• Monitor closely if diabetic

Carpal tunnel syndrome

• Related to prolonged water retention and soft tissue swelling
• More likely at high doses over extended periods
• Reversible with dose reduction or cessation

Worsening of diabetic retinopathy

• GH and IGF-1 can potentially worsen proliferative retinopathy
• Contraindication in active proliferative diabetic retinopathy

Theoretical cancer concerns

• IGF-1 elevation has theoretical cancer concerns (cell proliferation)
• No confirmed clinical signal from ipamorelin specifically
• Avoid in active cancer or recent cancer history

Dose-Related Side Effect Pattern

Low dose (100 mcg 1–2× daily)

• Mostly well tolerated
• Mild or no side effects
• Effects also modest

Standard dose (200–300 mcg 2–3× daily)

• Good efficacy-to-side-effect ratio
• Mild side effects common but manageable
• Most clinical and research use here

High dose (400–500+ mcg per injection)

• Diminishing returns — receptor saturation
• Side effects more pronounced
• Not generally recommended

Side Effect Management

For injection site reactions

• Rotate injection sites (abdomen, thigh, deltoid)
• Let alcohol dry completely before injection
• Use fresh needles each injection
• Ice briefly after injection if irritation is consistent

For headaches

• Increase water intake
• Over-the-counter acetaminophen or ibuprofen short-term
• Reduce dose temporarily if severe
• Usually resolves within 2 weeks

For water retention

• Hydrate well (paradoxically helps)
• Maintain sodium-potassium balance
• Usually resolves after 2–4 weeks of continued use
• Reduce dose if persistent

For blood sugar concerns

• Monitor fasting glucose if at risk
• Maintain carbohydrate balance — avoid both severe restriction and excess
• Ensure adequate physical activity
• Discuss with provider if HbA1c rises meaningfully

When to Stop

• Persistent severe headaches
• Edema interfering with daily function
• Signs of carpal tunnel
• Unexplained changes in vision
• New or worsening blood sugar problems
• Any sign of allergic reaction

Comparison to Other GH Secretagogues

GHRP-2

• Stronger GH pulse
• Significant cortisol and prolactin elevation
• More significant hunger stimulation

GHRP-6

• Similar to GHRP-2 with more cortisol/prolactin effects
• Very strong hunger stimulation

Hexarelin

• Strongest GH release
• Notable cortisol/prolactin elevation
• Can affect heart rate at high doses

Ipamorelin

• Moderate GH release
• No significant cortisol/prolactin
• Clean side effect profile
• Best tolerability across the class

Who Should Avoid Ipamorelin

• Active cancer or cancer history within 5 years
• Active proliferative diabetic retinopathy
• Uncontrolled diabetes
• Pregnancy or breastfeeding
• Critical illness
• Hypersensitivity to ipamorelin or components

Bottom Line

Ipamorelin is the cleanest option in the GHRP class. Most side effects are mild and transient — headaches, water retention, injection site irritation. Serious side effects are rare at standard doses. Monitor blood sugar if you're at risk. Avoid if you have active cancer or proliferative retinopathy.

See the ipamorelin guide. Related: cost, CJC-1295 stack.